Ali Mohammad Sabzghabaee Selected Research

Therapeutics

1/2019	Risk of Seizure after Naloxone Therapy in Acute Tramadol Poisoning: A Systematic Review with Meta-Analysis.
8/2015	Is Admission Serum Sodium Concentration a Clinical Predictor for the Outcome of Therapy in Critically Ill Poisoned Patients?
8/2015	Clinical Presentation and the Outcome of Therapy in a Cohort of Patients with Methadone Toxicity in Iran.
2/2015	Adherence to statin therapy in patients with type 2 diabetes: An important dilemma.
1/2015	Risk factors and the outcome of therapy in patients with seizure after Carbamazepine poisoning: A two-year cross-sectional study.
5/2014	Naloxone therapy in opioid overdose patients: intranasal or intravenous? A randomized clinical trial.
1/2014	The outcome of agitation in poisoned patients in an Iranian tertiary care university hospital.
5/2011	Role of menthol in treatment of candidial napkin dermatitis.
1/2011	Amitraz poisoning treatment: still supportive?

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ali Mohammad Sabzghabaee Research Topics

Disease

28	Poisoning 04/2021 - 01/2011
4	Type 2 Diabetes Mellitus (MODY) 04/2017 - 01/2011
3	Wounds and Injuries (Trauma) 01/2022 - 12/2011
3	Tachycardia (Tachyarrhythmias) 04/2021 - 07/2016
3	Dyslipidemias (Dyslipidemia) 02/2015 - 01/2013
2	Dermatitis 01/2022 - 05/2011
2	Pain (Aches) 01/2022 - 04/2021
2	Infections 01/2022 - 01/2022
2	Fever (Fevers) 01/2022 - 03/2012
2	Burns 01/2022 - 07/2012
2	Opiate Overdose 01/2021 - 05/2014
2	Breast Neoplasms (Breast Cancer) 01/2016 - 01/2013
2	Mental Disorders (Mental Disorder) 08/2015 - 07/2013
2	Cardiovascular Diseases (Cardiovascular Disease) 02/2015 - 01/2014
2	Coma (Comas) 03/2012 - 11/2011
2	Denture Stomatitis 03/2012 - 12/2011
1	Duodenal Ulcer (Curling's Ulcer) 01/2022
1	Keratoconjunctivitis Sicca 01/2022
1	Ulcer 01/2022
1	Low Back Pain (Lumbago) 04/2021
1	Common Cold 04/2021
1	Acidosis 04/2021
1	Postpartum Depression (Post-Natal Depression) 01/2021
1	Aspiration Pneumonia 01/2021
1	Drug Overdose 10/2020
1	Anemia 07/2018
1	Disease Progression 01/2018
1	Pulmonary Edema 10/2016
1	Atherosclerosis 09/2015
1	Critical Illness (Critically Ill) 08/2015
1	Opioid-Related Disorders (Opiate Addiction) 08/2015
1	Respiratory Insufficiency (Respiratory Failure) 05/2014
1	Nervous System Diseases (Neurological Disorders) 01/2014
1	Substance Withdrawal Syndrome (Withdrawal Symptoms) 01/2014
1	Neoplasms (Cancer) 01/2013
1	Body Weight (Weight, Body) 01/2013
1	Asthma (Bronchial Asthma) 10/2012
1	Hypertension (High Blood Pressure) 09/2012
1	Overweight 09/2012

Drug/Important Bio-Agent (IBA)

12	Pharmaceutical PreparationsIBA 01/2022 - 02/2011
5	Methadone (Dolophine)FDA LinkGeneric 10/2020 - 07/2013
4	Opioid Analgesics (Opioids)IBA 01/2021 - 01/2014
4	Tramadol (K315)FDA LinkGeneric 10/2020 - 03/2014
4	Naloxone (Narcan)FDA LinkGeneric 01/2019 - 03/2014
4	Tricyclic Antidepressive Agents (Tricyclic Antidepressants)IBA 07/2016 - 01/2012
3	Metformin (Glucophage)FDA LinkGeneric 04/2021 - 01/2011
3	BenzodiazepinesIBA 01/2015 - 01/2012
2	Acetaminophen (Paracetamol)FDA LinkGeneric 04/2021 - 03/2012
2	Antipsychotic Agents (Antipsychotics)IBA 04/2021 - 01/2018
2	Antidepressive Agents (Antidepressants)IBA 04/2021 - 01/2018
2	Midazolam (Versed)FDA LinkGeneric 07/2016 - 07/2012
2	LigandsIBA 01/2016 - 01/2013
2	Lipoproteins (Lipoprotein)IBA 01/2014 - 12/2011
2	Apolipoproteins E (ApoE)IBA 01/2014 - 12/2011
2	Blood Glucose (Blood Sugar)IBA 09/2012 - 02/2011
2	Volatile Oils (Essential Oils)IBA 03/2012 - 12/2011
1	Sucralfate (Carafate)FDA LinkGeneric 01/2022
1	Methocarbamol (Robaxin)FDA LinkGeneric 04/2021
1	Indomethacin (Indometacin)FDA LinkGeneric 04/2021
1	Therapeutic UsesIBA 04/2021
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 04/2021
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2021
1	Tuberculin (PPD)IBA 01/2021
1	Vitamin B 6IBA 01/2021
1	OpiumIBA 10/2020
1	ParaquatIBA 01/2019
1	Dosage Forms (Dosage Form)IBA 10/2018
1	PesticidesIBA 07/2018
1	Interferon-betaIBA 01/2018
1	TabletsIBA 04/2017
1	Capsules (Microcapsules)IBA 04/2017
1	Biomarkers (Surrogate Marker)IBA 01/2016
1	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 09/2015
1	SodiumIBA 08/2015
1	Methamphetamine (Desoxyn)FDA LinkGeneric 07/2015
1	LDL CholesterolIBA 02/2015
1	Coenzyme A (CoA)IBA 02/2015
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 02/2015
1	Acetylcysteine (Siran)FDA LinkGeneric 01/2015
1	Methylene Blue (Methylthioninium Chloride)FDA Link 01/2015
1	Ascorbic Acid (Vitamin C)FDA LinkGeneric 01/2015
1	AluminumIBA 01/2015
1	Carbamazepine (Tegretol)FDA LinkGeneric 01/2015
1	Narcotic Antagonists (Opioid Antagonists)IBA 03/2014
1	Naltrexone (ReVia)FDA LinkGeneric 01/2014
1	PowdersIBA 01/2013
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2013
1	EphB4 ReceptorIBA 01/2013
1	LipidsIBA 01/2013
1	CholesterolIBA 09/2012
1	Triglycerides (Triacylglycerol)IBA 09/2012
1	HDL LipoproteinsIBA 09/2012

Therapy/Procedure

9	Therapeutics 01/2019 - 01/2011
3	Length of Stay 01/2022 - 07/2018
3	Drug Therapy (Chemotherapy) 01/2021 - 01/2011
2	Critical Care (Surgical Intensive Care) 07/2016 - 07/2012
1	Radiotherapy 01/2022
1	Hemoperfusion 01/2019
1	Artificial Respiration (Mechanical Ventilation) 01/2018
1	Complementary Therapies (Alternative Medicine) 10/2014